COOPERS DRY COW INTRAMAMMARY ANTIBIOTIC

Negara: Australia

Bahasa: Inggris

Sumber: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Beli Sekarang

Selebaran informasi Selebaran informasi (PIL)
20-06-2017
Karakteristik produk Karakteristik produk (SPC)
20-06-2017

Bahan aktif:

CLOXACILLIN AS THE BENZATHINE SALT; BRILLIANT BLUE FCF

Tersedia dari:

INTERVET AUSTRALIA PTY LIMITED

INN (Nama Internasional):

cloxacillin as benzathine(600mg/Sg)

Bentuk farmasi:

MISC. INTRA MAMMARY

Komposisi:

CLOXACILLIN AS THE BENZATHINE SALT ANTIBIOTIC Active 600.0 mg/3.6gS; BRILLIANT BLUE FCF DYE-BLUE Other 25.0 mg/3.6gS

Unit dalam paket:

*3.6g Syr; *Carton 20; 3.6g Syr; Bucket 100

Kelas:

VM - Veterinary Medicine

Diproduksi oleh:

INTERVET AUSTRALIA

Kelompok Terapi:

DAIRY CATTLE | BOVINE | BREEDERS | CALVES | DAIRY COW | GROWERS | LACTATING COW | MILKING COW

Area terapi:

ANTIBIOTIC & RELATED

Indikasi Terapi:

CORYNEBACTERIUM SPP. | MASTITIS | STAPHYLOCOCCUS SPP. | STREPTOCOCCUS SPP. | BACTERIAL CANKER | STAPHYLOCOCCOSIS | SUBCLINICAL MASTITIS

Ringkasan produk:

Poison schedule: 4; Withholding period: WHP: Milk - do not use in lactating cow s or within 35 days of calving. After calving colostrum or milk from treated dry cows must not be used for human co nsumption or processing for 96 hours (8 milkings). Meat: do not use less than 30 days before slaughter for human con sumption.; Host/pest details: DAIRY CATTLE: [CORYNEBACTERIUM SPP., MASTITIS, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP.]; Poison schedule: 4; Withholding period: ; Host/pest details: DAIRY CATTLE: [CORYNEBACTERIUM SPP., MASTITIS, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP.]; For the control in dairy cows of mastitis caused by streptococcus spp., staphylococcus spp., (including penicillin resistant strains), corynebacterium app., and other organisms susceptible to cloxacillin.Not to be used in lactating cows or within 35 days of calving. If accidentally administered within 35 days of calving or to a lactating animal, contact your prescribing veterinarian for advice. Do not use in cows exhibiting sensitivity to penicillin.

Status otorisasi:

Registered

Tanggal Otorisasi:

2023-07-01

Selebaran informasi

                                File Name:
Dry Cow 01-0521.doc
Prepared By:
L. Wirth
Preparation Date:
11/9/2001
Last Revised:
n/a
Schering-Plough Label & Printer
Specifications:
CCP 01/015
Version:
1
(11/9/2001)
Page 1 of 9
DRY COW – PRIMARY PACK (1) CARTON
MAIN PANEL – FRONT & ENDS
20 X 3.6g CARTON
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
COOPERS®
DRY COW
INTRAMAMMARY ANTIBIOTIC
Each 3.6g Syringe contains 600mg CLOXACILLIN (as Benzathine Salt)
Also contains 25mg Brilliant Blue FCF
For the control in dairy cows of mastitis caused by _Streptococcus_
spp., _ Staphylococcus_ spp. (including
penicillin resistant strains), _Corynebacterium_ spp. and other
organisms susceptible to cloxacillin.
20 SYRINGES EACH 3.6G NET
COOPERS LOGO
DRY COW – PRIMARY PACK (1) CARTON
TOP PANEL
20 X 3.6g CARTON
COOPERS®
DRY COW
INTRAMAMMARY ANTIBIOTIC
COOPERS LOGO
File Name:
Dry Cow 01-0521.doc
Prepared By:
L. Wirth
Preparation Date:
11/9/2001
Last Revised:
n/a
Schering-Plough Label & Printer
Specifications:
CCP 01/015
Version:
1
(11/9/2001)
Page 2 of 9
DRY COW – PRIMARY PACK (1) CARTON
REAR PANEL
20 X 3.6g CARTON
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
DIRECTIONS FOR USE
RESTRAINTS:
NOT TO BE USED IN LACTATING COWS OR WITHIN 35 DAYS OF CALVING. IF
ACCIDENTALLY ADMINISTERED
WITHIN 35 DAYS OF CALVING OR TO A LACTATING ANIMAL, CONTACT YOUR
PRESCRIBING VETERINARIAN FOR
ADVICE.
DO NOT USE IN COWS EXHIBITING SENSITIVITY TO PENICILLIN.
DOSAGE AND ADMINISTRATION:
DOSE: One syringe per quarter immediately after the final milking of a
lactation.
ADMINISTRATION: At the final milking of a lactation, milk the cow
normally. Clean and disinfect the teat
ends using rubbing alcohol or iodophors or other suitable cleanser.
Infuse the contents of one syringe
into each quarter and leave without further milking. Wear clean rubber
gloves when applying. Dip all
teats after infusion, in an approved teat disinfectant.
WITHHOLDING PERIODS:
MILK: DO NOT USE IN LACTATING COWS OR WITHIN 35 DAYS OF CALVING. AFTER
CALVING, COLOSTRUM O
                                
                                Baca dokumen lengkapnya
                                
                            

Karakteristik produk

                                PRODUCT NAME: COOPERS® DRY COW INTRAMAMMARY ANTIBIOTIC
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY, 2009
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: 1 800 033 461
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Antibiotic preparation in a suitable medium.
TRADE NAME:
COOPERS
® DRY COW INTRAMAMMARY ANTIBIOTIC
RECOMMENDED USE:
Intramammary infusion to treat bovine mastitis.
APVMA NO:
54660
CREATION DATE:
July, 2009
THIS VERSION ISSUED:
July, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code. However, this is a C1 Combustible
Liquid and for storage meets the definition of Dangerous Goods.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S24/25. Avoid contact with skin and eyes.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
Blue viscous liquid.
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product. This is
an antibiotic preparation.
Any person with a history of allergies to this class of substances
should avoid all contact with this product as it may cause
sensitisation.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. In addition
product is unlikely to
cause any discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. In addition product is unlikely to cause any discomfort in
normal use.
LONG TERM EXPOSURE:
No data for health effects associated with long term skin exposure.
EYE CONTACT:
SHORT 
                                
                                Baca dokumen lengkapnya